Navigation Links
Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions
Date:5/11/2009

NATICK, Mass., May 11 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and news announcements at the 30th Annual Scientific Sessions of the Heart Rhythm Society, which run from May 13 to 16 in Boston. Highlights of the week's events include late-breaking trial presentations from the MADIT II clinical trial and the ALTITUDE Clinical Science Program. These presentations will provide new insights for implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) patients.

Schedule of Events (all times are Eastern Time)

Tuesday, May 12

  • Cardiac Rhythm Management Allied Health Symposium. The Company will sponsor the "Tenth Annual Essentials of CRM Therapy and Patient Management," chaired by Mark Heimann, MSN, CS, CRNP, from 7:30 a.m. to 2:30 p.m. in the America Ballroom at the Westin Copley Place Hotel, 10 Huntington Ave., Boston. This symposium is designed to provide clinicians with practical knowledge on the care and management of patients who have an implantable CRM device or are undergoing an electrophysiology procedure.

Wednesday, May 13

  • Insights into Percent Biventricular Pacing in Heart Failure Patients. David L. Hayes, M.D., will present on the impact of biventricular pacing on CRT-D patients from the ALTITUDE Clinical Science Program. This observational cohort study analyzes data from more than 100,000 remote monitoring patients and looks at the relative risk of mortality among patients grouped by the percent biventricular pacing therapy they receive. The results will be presented during a poster session from 5:45 to 7:00 p.m. in the Grand Ballroom at the Westin Waterfront Hotel, 425
    '/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Xconomy Launches XSITE 2009; First Annual Xconomy Summit on Innovation, Technology, and Entrepreneurship at Boston University
2. UMass Boston Opens Venture Development Center to Expand R&D Activity
3. Boston Scientific Announces First Quarter Special Items
4. Boston Scientific Launches New Coronary Imaging Catheter
5. Moodys Raises Boston Scientifics Rating Outlook to Stable
6. BG Medicine Signs Collaborative Research Agreement with the National Heart, Lung and Blood Institute (NHLBI), and Boston University
7. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual Cowen and Company Healthcare Conference in Boston
8. Boston LASIK Eye Surgery Expert Dr. Peter Rapoza Joins Select Group of Doctors in Trusted LASIK Surgeons Directory
9. Boston Scientific Resolves Outstanding Litigation Matter, Finalizes Goodwill Impairment Charge
10. Boston Scientific Announces Japanese Approval for TAXUS(R) Liberte(R) Drug-Eluting Stent System
11. Biotechnology Veteran Michael Webb Joins Boston-based Investment Bank as Senior Advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)SAN FRANCISCO, Dec. 3 VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today anno
(Date:12/3/2009)HOPKINTON, Mass., Dec. 3 Caliper Life Sciences, Inc. (Nasdaq: CALP ), a leading provider of tools and services for drug discovery and life sciences research, today introduced Living Image 4.0 softwa
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Neurostimulation - A Global Market Perspective ,, http://www.reportlinker.com/p01642
(Date:12/2/2009)COPENHAGEN, Dec. 2 The world,s first concept demonstration tires made with BioIsoprene technology, a breakthrough alternative to replace a petrochemically produced ingredient in the manufacture of
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3
...information officers made the Computerworld magazi...n Harper, CIO of Modine Manufacturing Co. , in Ra...tems such as cooling for a new soccer stadium in L...en active in fuel-cell development. , , Matthew Ly...es Inc. , in Green Bay. ShopKo has 137 stores unde...
...uaSensors , a Milwaukee-area company that makes an...eceived a $360,000 investment from local angel gro... is a system in which various sensors for water, w...er, and other applications can be attached to a st... computer data. One of its main selling points is ...
...promised, our latest e-mail newsletter contains th...our readership has increased from around 30,000 v... them sticking around to read more than a few stor...t. , ,Let me take a moment to thank everyone who h...ce isnt until March 2 and were more than a third f...
Other Biology Technology:
(Date:12/3/2009)A coating on windows or solar panels that repels grime and dirt? Expanded battery storage capacities for the next electric car? New Tel Aviv University research, just published in Nature Nanotechnolo
(Date:12/3/2009)Coral reef fish can undergo a personality change in warmer water, according to an intriguing new study suggesting that climate change may make some species more aggressive. , Experiments with two spe
(Date:12/3/2009)UPTON, NY A team of scientists from the U.S. Department of Energy,s (DOE) Brookhaven National Laboratory, Harvard University, and the Indian Institute of Science has made a major step in understandin
Breaking Biology News(10 mins):A window that washes itself? 2Fish with attitude: Some like it hot 2Grooving down the helix 2Grooving down the helix 3FaxBack Announces a New VoIP Fax ATA based on HTTPS Which Provides a Level of Quality for VoIP Faxing Equal to PSTN Connections 56102 1FaxBack Announces a New VoIP Fax ATA based on HTTPS Which Provides a Level of Quality for VoIP Faxing Equal to PSTN Connections 56102 2The Center for Courageous Kids and Xytex Cryo International Bring Dreams Alive for Exceptional Kids 56099 1The Center for Courageous Kids and Xytex Cryo International Bring Dreams Alive for Exceptional Kids 56099 2The Center for Courageous Kids and Xytex Cryo International Bring Dreams Alive for Exceptional Kids 56099 3Net32 Inc Reports Highest Customer Ratings Ever 56096 1Net32 Inc Reports Highest Customer Ratings Ever 56096 2
...nformation about a specific mechanism involved in ...ndings, published in the June issue of Cancer Cell...growth factor receptor (EGFR). , EGFR is a well-st...rowth by transmitting growth factor signals acting...ally elevated levels in human cancer cells. Increa...
...anufacturing and pharmaceutical industries can rep...event heart failure in mice with the genetic mutat...ding to scientists at the University of Michigan M...ne causes the progressive deterioration of skeleta... affects cardiac muscle, too. Many people with Duc...
...te University researchers will use a $4 million gr...r the functions of genes in a plant - research whi...alth and agriculture. , In a collaborative effort ...determine the functions of roughly 4,400 nuclear g...flowering plant whose entire 29,000 gene sequence ...
Other Biology News:Physical and functional interaction of key cell growth molecules linked to cancer 2Chemical 'band-aid' prevents heart failure in mice with muscular dystrophy 2Chemical 'band-aid' prevents heart failure in mice with muscular dystrophy 3Chemical 'band-aid' prevents heart failure in mice with muscular dystrophy 4MSU researchers receive $4 million grant to uncover gene functions 2
...atin M (OSM) is a pleiotropic cytokine produced by... cells. OSM inhibits the growth of some tumour and...uscle and Kaposis sarcoma cell proliferation, cyto...y lipoprotein receptor expression on hepatoma cell...
...D2000 syringe pump series combines Harvard Apparat...nterface and a wide range of configuration options...e dimensions of syringes from all the major manufa...all the pertinent information from across the lab....
Mouse Anti-Nop5p, Nop58p Monoclonal Antibody, Unconjugated, Clone 34B12 from Abcam
Corning Gaps Ii Bar-Coded Coated Slides from Sigma-Aldrich
Biology Products: